175 related articles for article (PubMed ID: 22484811)
1. Treating myeloma cast nephropathy without treating myeloma.
Leung N
J Clin Invest; 2012 May; 122(5):1605-8. PubMed ID: 22484811
[TBL] [Abstract][Full Text] [Related]
2. Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model.
Ying WZ; Allen CE; Curtis LM; Aaron KJ; Sanders PW
J Clin Invest; 2012 May; 122(5):1777-85. PubMed ID: 22484815
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute kidney injury with cast nephropathy.
Walther C; Podoll AS; Finkel KW
Clin Nephrol; 2014 Jul; 82(1):1-6. PubMed ID: 24725380
[TBL] [Abstract][Full Text] [Related]
4. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
[TBL] [Abstract][Full Text] [Related]
5. Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy.
Huang ZQ; Sanders PW
Lab Invest; 1995 Dec; 73(6):810-7. PubMed ID: 8558842
[TBL] [Abstract][Full Text] [Related]
6. Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.
Manohar S; Nasr SH; Leung N
Curr Hematol Malig Rep; 2018 Jun; 13(3):220-226. PubMed ID: 29725932
[TBL] [Abstract][Full Text] [Related]
7. Crystalline Light Chain Casts and Hypercalcemia Induced Acute Kidney Injury: A Rare Presentation of Multiple Myeloma.
Nishigaito T; Mitsumoto K; Katsunuma R; Hirai Y; Yamashita C; Mizumoto A; Uzu T
Intern Med; 2024 Jun; 63(12):1751-1755. PubMed ID: 37926541
[TBL] [Abstract][Full Text] [Related]
8. Management options for cast nephropathy in multiple myeloma.
Cockwell P; Hutchison CA
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
[TBL] [Abstract][Full Text] [Related]
10. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
[TBL] [Abstract][Full Text] [Related]
12. Rapid reduction of extremely high kappa free light chains in a patient with myeloma cast nephropathy.
Snozek CLH; Kinard TN; Adamski J
J Clin Apher; 2018 Jun; 33(3):439-443. PubMed ID: 29427353
[TBL] [Abstract][Full Text] [Related]
13. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report.
Donati G; Zappulo F; Croci Chiocchini AL; Comai G; Zamagni E; La Manna G
Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of acute kidney impairment in patients with multiple myeloma.
Batuman V
Adv Chronic Kidney Dis; 2012 Sep; 19(5):282-6. PubMed ID: 22920637
[TBL] [Abstract][Full Text] [Related]
15. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
Peters NO; Laurain E; Cridlig J; Hulin C; Cao-Huu T; Frimat L
Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
[TBL] [Abstract][Full Text] [Related]
16. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study.
Lin ZS; Qin AB; Wang SX; Yu XJ; Dong B; Xiong ZY; Chen MH; Zhou FD; Zhao MH
J Nephrol; 2021 Aug; 34(4):1169-1177. PubMed ID: 33394345
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
[TBL] [Abstract][Full Text] [Related]
18. Myeloma light chain cast nephropathy, a review.
Sathick IJ; Drosou ME; Leung N
J Nephrol; 2019 Apr; 32(2):189-198. PubMed ID: 29730782
[TBL] [Abstract][Full Text] [Related]
19. The role of immunological assessment in patients with acute kidney injury and possible myeloma.
Lachmann HJ; Wassef NL
Adv Chronic Kidney Dis; 2012 Sep; 19(5):287-90. PubMed ID: 22920638
[TBL] [Abstract][Full Text] [Related]
20. [Renal involvement in multiple myeloma. Physiopathology and therapy].
Fiorini F; Napoli S; Giordano L; Castelluccio A
Minerva Urol Nefrol; 1995 Sep; 47(3):125-31. PubMed ID: 8815549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
